We thought the answer was YES.
Good table with the quality criteria they assessed. They state in the methods that they exclude studies with quality less than 3 but they include them in the list of studies in Table 1 and 2. They don't explicitly assess quality of cross-over trials separately, particularly with the washout period problem and assessment of period effects.